You are now leaving Kedrion Corporate site. Medical information including licensed uses may be different outside of the EU countries.
NO
YES
  1. CORPORATE - 16-02-2015

    Kedrion CEO took part in "Italy meets the USA" summit on February 10, 2015

    The NY meeting was aimed at highlighting significant investment opportunities in Italy

    read more 
  2. PLASMA & BIOTHERAPIES - 05-02-2015

    SIPPET Study: interim analysis confirms the original hypothesis

    The Study on inhibitors in Hemophilia A is safe to continue after Investigators’ Meeting in San Francisco (Dec 2014)

    read more 
  3. EVENTS - 12-01-2015

    Fighting diseases of the new-born: Kedrion attended UENPS conference

    The company also supported a mini-marathon to eradicate HDFN

    read more 

Pages

For more information please contact: pressoffice@kedrion.com